000 | 01749 a2200565 4500 | ||
---|---|---|---|
005 | 20250516023041.0 | ||
264 | 0 | _c20110614 | |
008 | 201106s 0 0 eng d | ||
022 | _a1873-2518 | ||
024 | 7 |
_a10.1016/j.vaccine.2011.01.053 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aWang, Ling-yun | |
245 | 0 | 0 |
_aSafety and immunogenicity of two freeze-dried Vero cell rabies vaccines for human use in post-exposure prophylaxis. _h[electronic resource] |
260 |
_bVaccine _cMar 2011 |
||
300 |
_a2679-81 p. _bdigital |
||
500 | _aPublication Type: Comparative Study; Journal Article; Randomized Controlled Trial | ||
650 | 0 | 4 | _aAdolescent |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 | _aAged, 80 and over |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAntibodies, Neutralizing _xblood |
650 | 0 | 4 |
_aAntibodies, Viral _xblood |
650 | 0 | 4 |
_aBiotechnology _xmethods |
650 | 0 | 4 | _aCell Culture Techniques |
650 | 0 | 4 | _aChild |
650 | 0 | 4 | _aChild, Preschool |
650 | 0 | 4 | _aChina |
650 | 0 | 4 | _aChlorocebus aethiops |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aFreeze Drying |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aPost-Exposure Prophylaxis _xmethods |
650 | 0 | 4 |
_aRabies Vaccines _xadverse effects |
650 | 0 | 4 | _aTechnology, Pharmaceutical |
650 | 0 | 4 |
_aVaccination _xmethods |
650 | 0 | 4 | _aVero Cells |
650 | 0 | 4 | _aYoung Adult |
700 | 1 | _aSun, Mei-ping | |
700 | 1 | _aZhang, Xue-chun | |
700 | 1 | _aSuo, Luo-dan | |
700 | 1 | _aXu, Ruo-hui | |
700 | 1 | _aZou, Yan-jie | |
700 | 1 | _aZuo, Li-bo | |
700 | 1 | _aQi, Hua | |
773 | 0 |
_tVaccine _gvol. 29 _gno. 15 _gp. 2679-81 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.vaccine.2011.01.053 _zAvailable from publisher's website |
999 |
_c20575114 _d20575114 |